FDA Approved: COLCRYS — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

View source ↗

Summary

FDA approved a supplemental application for COLCRYS (colchicine) from Takeda Pharmaceuticals America, Inc., indicating changes to its labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Mediterranean Fever
• Gout
• Pericarditis

Drugs mentioned

• COLCRYS (COLCHICINE)

Snippet

SUPPL AP for COLCRYS (COLCHICINE)